| Baseline (n = 604) | Follow-up | P value | |
---|---|---|---|---|
Dropouts (n = 204) | Participants (n = 400) | |||
Age (years), mean (SD) [min–max] | 59.6 (15.2) [18–90] | 54.9 (16.4) [18–86] | 62.0 (14.0) [18–90] | < 0.001a |
Sex, female n (%) | 402 (66.6) | 126 (61.8) | 276 (69.0) | 0.075b |
Education, university education n (%) | 145 (24.9) | 42 (21.3) | 103 (26.7) | 0.156b |
Baseline activity (score 3–19), median (IQR) [min–max] | 9.0 (5.0) [3–19] | 8.0 (5.0) [3–19] | 9.0 (5.0) [3–19] | 0.004c |
Confident to change (1–10), median (IQR) [min–max] | 7.0 (3.0) [1–10] | 6.5 (3.0) [1–10] | 7.0 (3.0) [1–10] | 0.593c |
Important to change (1–10), median (IQR) [min–max] | 8.0 (3.0) [1–10] | 8.0 (3.0) [1–10] | 7.0 (4.0) [1–10] | 0.266c |
Diagnosesd | ||||
 Musculoskeletal diseases, yes n (%) | 341 (58.9) | 102 (54.3) | 239 (61.1) | 0.116b |
 Circulatory diseases, yes n (%) | 284 (49.1) | 77 (41.0) | 207 (52.9) | 0.007b |
 Endocrine diseases, yes n (%) | 222 (38.3) | 66 (35.1) | 156 (39.9) | 0.267b |
 Mental health disorders, yes n (%) | 171 (29.5) | 70 (37.2) | 101 (25.8) | 0.005b |
 Respiratory diseases, yes n (%) | 168 (29.0) | 64 (34.0) | 104 (26.6) | 0.065b |
 Number of diagnoses, median (IQR) [min–max] | 7.0 (5.00) [0–18] | 6.00 (5.00) [0–15] | 7.00 (5.00) [0–18] | 0.887c |
Health care usee | ||||
 Number of office visits, median (IQR) [min–max] | 13.0 (21.0) [1–119] | 13.0 (22.0) [1–116] | 14.0 (19.0) [1–119] | 0.715c |
 ≥ 1 hospital stay, yes n (%) | 148 (24.5) | 49 (26.1) | 99 (25.2) | 0.821b |
 Prescribing professional group, physician n (%) | 169 (28.0) | 58 (28.4) | 111 (27.8) | 0.860b |
 Prescribing setting, primary care n (%) | 490 (81.1) | 158 (77.5) | 332 (83.0) | 0.099b |
 Used counselor support after PAP, yes n (%) | 208 (34.4) | 59 (28.9) | 149 (37.3) | 0.042b |